IMUNON Trademark

Trademark Overview

On Monday, September 20, 2021, a trademark application was filed for IMUNON with the United States Patent and Trademark Office. The USPTO has given the IMUNON trademark a serial number of 97036154. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, July 17, 2026. This trademark is owned by Celsion Corporation. The IMUNON trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; biological analysis; providing scientific research information in the field of clinical trials; Development of pharmaceutical preparations for treating cancer; scientific and technological research in the fields of immunotherapy and oncology

Pharmaceutical preparations, namely, immunotherapies for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals for the treatment of cancer
imunon

General Information

Serial Number97036154
Word MarkIMUNON
Filing DateMonday, September 20, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, July 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and ServicesBiological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; biological analysis; providing scientific research information in the field of clinical trials; Development of pharmaceutical preparations for treating cancer; scientific and technological research in the fields of immunotherapy and oncology
Goods and ServicesPharmaceutical preparations, namely, immunotherapies for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 24, 2021
Primary Code005
First Use Anywhere DateMonday, September 19, 2022
First Use In Commerce DateMonday, September 19, 2022
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 24, 2021
Primary Code042
First Use Anywhere DateMonday, September 19, 2022
First Use In Commerce DateMonday, September 19, 2022

Trademark Owner History

Party NameIMUNON, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLAWRENCEVILLE, NJ 08648
US
Party NameCelsion Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648
US
Party NameCelsion Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648
US

Trademark Events

Event DateEvent Description
Thursday, September 23, 2021NEW APPLICATION ENTERED
Sunday, October 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 22, 2022ASSIGNED TO EXAMINER
Friday, July 1, 2022NON-FINAL ACTION WRITTEN
Friday, July 1, 2022NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 11, 2023FINAL REFUSAL WRITTEN
Wednesday, January 11, 2023FINAL REFUSAL E-MAILED
Wednesday, January 11, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 5, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 5, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, April 5, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 5, 2023ASSIGNED TO LIE
Wednesday, April 5, 2023EXAMINER'S AMENDMENT ENTERED
Monday, April 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 10, 2024SOU EXTENSION 1 FILED
Wednesday, January 10, 2024SOU EXTENSION 1 GRANTED
Friday, January 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024SOU EXTENSION 2 FILED
Tuesday, July 9, 2024SOU EXTENSION 2 GRANTED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 9, 2025SOU EXTENSION 3 FILED
Thursday, January 9, 2025SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 11, 2025SOU TEAS EXTENSION RECEIVED
Friday, July 11, 2025SOU EXTENSION 4 FILED
Friday, July 11, 2025SOU EXTENSION 4 GRANTED
Friday, July 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 12, 2026SOU TEAS EXTENSION RECEIVED
Wednesday, April 1, 2026AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 4, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 4, 2026ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Thursday, June 25, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 12, 2026RESPONSE TO ITU OFFICE ACTION ENTERED
Monday, January 12, 2026SOU EXTENSION 5 FILED
Monday, July 13, 2026SOU EXTENSION 5 GRANTED
Monday, July 13, 2026TEAS STATEMENT OF USE RECEIVED
Tuesday, July 14, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 12, 2026USE AMENDMENT FILED
Sunday, July 12, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, July 17, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 17, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

imunon cancer pharmaceutical preparations research treatment biological scientific development therapeutic biotechnology